A convicted extortionist is extracting settlements from digital health companies
A man who once tried to extort over $100 million from a Hollywood producer, several energy industry tycoons, and a Silicon Valley darling is now operating a scheme that’s draining thousands of dollars out of the digital health industry.
At a legal event we attended recently, a group of lawyers in digital health was giggling amongst themselves about receiving a demand letter from Vivek Shah. Letters and lawsuits from Shah have apparently become so ubiquitous that his name has become an inside joke among lawyers.
Six corporate lawyers told Second Opinion that Shah is one of the most prominent litigants suing thousands of corporations for allegedly violating the California Invasion of Privacy Act. Shah is using California’s 1960s-era wiretapping law, which has a private right of action, to accuse companies of violating his privacy for sharing his web data with marketers and other entities. CIPA wasn’t designed for the internet epoch, and lawyers are advising many companies to ignore demand letters from Shah. But it’s not that simple for digital health companies, which manage sensitive health information.
Several lawyers say they are advising digital health companies to pay the fee in some cases. Second Opinion has viewed a copy of two of the letters, one of which threatens the filing of an attached complaint. We incorporated a copy of the letter below for our premium subscribers.
Shah did not respond to a request for comment.
Reserve Your Spot for Upcoming Webinars!

An ongoing legal debate
The CIPA demand letters, which demand statutory damages for using web trackers without consent, strike at the center of an ongoing legal debate about patients' personal health information, or PHI, and how it’s legally protected. Federal and state regulators, as well as courts, have become increasingly preoccupied with protecting health data that is not covered by federal health privacy laws.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
Office Hours
A live Q&A with Christina Farr and Ruth Reader, exclusively for Second Opinion Premium members. Thursday, November 19, 1:30–2:30 p.m. ET / 10:30–11:30 a.m. PT.
The Shift Left & the Impact of the Midterms on Healthcare
Democrats just took both chambers. Aneesh Chopra, Christopher Kerns and Mike Desjadon join Ruth Reader and Christina Farr live to talk through what they'll try to do on healthcare — and what's actually achievable under a Republican White House.
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&